| IMRX Stock Up on FDA's Orphan Drug Tag for Pancreatic Cancer Drug | 10/16 11:25 | zacks.com |
| IMRX Stock Soars on Upbeat Efficacy Data From Pancreatic Cancer Study | 09/16 10:15 | zacks.com |
| Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients | 09/12 16:05 | globenewswire.com |
| Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates | 08/06 16:05 | globenewswire.com |
| Why is Immuneering (IMRX) Stock Up 24% Today? | 08/01 15:36 | investorplace.com |
| Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer | 07/31 16:05 | globenewswire.com |
| 3 Penny Stocks With 735% Average Upside, According to Wall Street | 07/09 10:47 | 247wallst.com |
| Immuneering to Present at the Jefferies Global Healthcare Conference | 05/29 16:05 | globenewswire.com |
| Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates | 05/07 16:05 | globenewswire.com |
| Immuneering Recognizes Melanoma Awareness Month | 05/06 16:30 | globenewswire.com |